Do not combine these compounds without baseline bloodwork and regular monitoring
It may also be used to treat other conditions, such as pernicious anemia, vitamin B12 malabsorption, and certain types of nerve pain
Lopes, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Current FDA concern The FDA says compounded AOD-9604 may carry immunogenicity risks for some routes and may have problems linked to peptide impurities and product characterization
The peptide is still in the early stages of animal studies
Sequencing: For inpatient admissions, the condition established after study to be chiefly responsible for the admission should be sequenced as the principal diagnosis